H.J.J. Jansen

Jeroen Bosch Hospital, Ôs-Hertogenbosch
Nederland

Presentatie(s) van deze spreker

donderdag 24 april 2014 om 17:48 - 18:00

Liraglutide reverses insulin-associated weight gain, improves glycemic control and decreases insulin dose in patients with type 2 diabetes. Results from a 26-week, randomized, controlled trial (ELEGANT)